Q1WB
MRNA icon

Quest 10 Wealth Builders’s Moderna MRNA Stock Holding History

Quest 10 Wealth Builders’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3
Closed -$91 – 822
2025
Q4 		$91 Hold
3
– – ﹤0.01% 776
2025
Q3 		$79 Hold
3
– – ﹤0.01% 860
2025
Q2 		$85 Hold
3
– – ﹤0.01% 776
2025
Q1 		$87 Buy
+3
New +$106 ﹤0.01% 759

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quest 10 Wealth Builders's MRNA Position: Q1 2026 in Review

Quest 10 Wealth Builders sold out of Moderna (MRNA) in Q1 2026, closing a stake of 3 shares — an estimated $91 sold.

Quest 10 Wealth Builders first reported a position in MRNA in Q1 2025 and held it in 4 quarters. The position peaked at $91 in Q4 2025. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Quest 10 Wealth Builders reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Quest 10 Wealth Builders sold 3 Moderna shares in Q1 2026, an estimated $91.
  • Quest 10 Wealth Builders first reported a position in Moderna in Q1 2025 and held it in 4 quarters.
  • Quest 10 Wealth Builders's Moderna position peaked at $91 in Q4 2025.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q1 2026, filed 6 May 2026.